me medica cal ma marijuana te testing advisor advisory
play

Me Medica cal Ma Marijuana Te Testing Advisor Advisory Council - PowerPoint PPT Presentation

Me Medica cal Ma Marijuana Te Testing Advisor Advisory Council Council October 24, 2019 Councils Charge A.R.S. 36 2821(B) The MMJ Testing Advisory Council shall make recommendationsregarding: Establishing a required testing


  1. Me Medica cal Ma Marijuana Te Testing Advisor Advisory Council Council October 24, 2019

  2. Council’s Charge

  3. A.R.S. §36 ‐ 2821(B) The MMJ Testing Advisory Council shall make recommendations…regarding: • Establishing a required testing program • Testing and potency standards • Procedural requirements for collection, storing, and testing • Reporting results to patients and the department • Remediation and disposal requirements

  4. Review of timeline and steps for lab certification

  5. Lab Certification Process ● Administrative Review (30 days) ○ NOD or Notification of Admin Complete ■ Lab has 90 days to respond to an NOD ● Substantive Review (60 days) ○ RFI ■ Lab has 10 days to respond to an RFI ○ Inspection ■ SOD and POC

  6. Review of current lab testing practices – Tabitha Hauer

  7. Discussion/recommendations of testing and potency standards

  8. NOTE: The following slides are intended as a starting point for Council discussion based on information presented at the initial Council meeting on 9/26/19.

  9. Key Discussion Points ● What parameters should be tested for within each category? ● What is the safety level before a product must be remediated or disposed? ● What test method options should be used?

  10. Considerations for Discussion ● Statutory intent is to detect “unsafe levels” and confirm potency ● What framework should guide setting action levels? Variable? Protective for children? For immunocompromised? ● Consider requiring existing methods OR in- house developed methods meeting method criteria of previously validated methods

  11. Microbial Contamination

  12. E. coli Considerations Microbial Contamination

  13. Aspergillus Considerations ● Option: Test for Aspergillus flavuus, fumigatus, niger, terreus ○ If positive, product cannot be sold OR ○ If positive, product cannot be sold in an inhalable form ● Option: Do not test; label inhalables with a warning that they may contain Aspergillus Microbial Contamination

  14. Methods ● Use Bacteriological Analytical Manual (FDA 2013a) and validated by AOAC Appendix J Microbial Contamination

  15. Additional Discussion ● Any other parameters for testing? ● Any other method options for testing? Microbial Contamination

  16. Heavy Metals

  17. Considerations ● Varying limits based on method of consumption ○ Inhalable ○ Other ● Any FDA/USP or in-house developed method that is validated by AOAC Appendix K and can meet the method criteria from the EPA methods Heavy Metals

  18. Metal Limit (ppm) Method Inhalable Other Arsenic 0.2 1.5 Any FDA/USP or in-house developed Cadmium 0.5 0.5 method that is validated by Lead 0.5 0.5 AOAC Appendix K Mercury 0.1 3.0 and can meet the method criteria from the Chromium 0.6 2.0 EPA methods Heavy Metals

  19. Additional Discussion ● Any other parameters for testing? ● Any other method options for testing? Heavy Metals

  20. Pesticides, Fungicides, Herbicides, Growth Regulators

  21. Considerations ● Utilize Oregon’s list of parameters plus at least one herbicide. ● Utilize Oregon’s safety limits and the USP limits for herbicides. ● Utilize any AOAC or in-house developed method that is validated by AOAC Appendix K and can meet the method criteria from the EPA methods. Pesticides, Fungicides, Herbicides, Growth Regulators

  22. Oregon List and Limits Pesticides, Fungicides, Herbicides, Growth Regulators

  23. Additional Discussion ● Any other parameters for testing? ● Any other method options for testing? Pesticides, Fungicides, Herbicides, Growth Regulators

  24. Residual Solvents

  25. Considerations ● Utilize Oregon’s list of parameters ● Utilize Oregon’s safety limits ● Any EPA, AOAC, or in-house developed method that is validated by AOAC Appendix K and can meet the method criteria from the EPA methods Residual Solvents

  26. Oregon List and Limits Residual Solvents

  27. Additional Discussion ● Any other parameters for testing? ● Any other method options for testing? Residual Solvents

  28. Potency Potency

  29. Considerations ● Create an Arizona cannabinoid list that includes the acid forms: THCa, CBDa, CBCa ● Test the cannabinoid list by AHP or in-house methods that are validated by AOAC Appendix K and can meet the method criteria from the EPA methods Potency

  30. Additional Discussion ● Set limits for THC, CBD, and/or CBC levels? ● Any other method options for testing? Potency

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend